Ifeoluwa Babatunde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ifeoluwa Babatunde has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Chima O. Oluigbo
Department of Neurosurgery, Children’s National Hospital, Washington, USA
1 shared publication - Courtney J. Wusthoff
Department of Neurology University of California, Davis Sacramento California USA
1 shared publication - Daniel A. Freedman
Department of Neurology, Dell Medical School at the University of Texas at Austin, Austin, TX, USA
1 shared publication - Dara V. F. Albert
Department of Pediatrics, Division of Pediatric Neurology, Nationwide Children's Hospital, The Ohio State University, Columbus; and
1 shared publication - Elissa G. Yozawitz
Isabelle Rapin Division of Child Neurology of the Saul R. Korey Department of Neurology and Department of Pediatrics Albert Einstein College of Medicine and Montefiore Einstein Bronx New York USA
1 shared publication - Erin Fecske
Department of Neurology, Children's Mercy Kansas City, Overland Park, KS, USA
1 shared publication
Latest Publications
- Open Access
- 8 April 2026
- Published by SAGE Publications in Epilepsy Currents
- Vol. 26 (3) , 174-202
American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
This practice guideline from the American Epilepsy Society provides evidence-based recommendations for pharmacological, dietary, and surgical therapies for epilepsy for infants and children from 1 month of age to <36 months. The multidisciplinary panel updated an existing systematic review, which was funded by the Patient-Centered Outcomes Research Institute and conducted by ECRI (formerly the Emergency Care Research Institute) on behalf of the Agency for Healthcare Research and Quality. The updated review used the same search strategy, inclusion/exclusion criteria, and Grading of Recommendations Assessment, Development and Education methodology, and added studies from August 2021 through September 2025 that were not in the original systematic review. As with the previous review, West syndrome and infantile spasms were excluded from this guideline, as existing treatment guidance is already available for infantile epileptic spasms. While many of the recommendations are conditional due to low certainty of evidence, the panel made two strong recommendations: (1) hemispherectomy/hemispherotomy surgery is recommended for infants and children <36 months of age with drug resistant epilepsy secondary to select underlying lesional pathologies, including but not limited to hemimegaloencephaly, Rasmussen's encephalitis, Sturge-Weber syndrome, perinatal stroke, and hemispheric cortical dysplasia; and (2) intralobar, multilobar, or focal resections or posterior disconnections for drug-resistant focal or lesional epilepsy in this same age range. A treatment algorithm was developed based on evidence and expert opinion as part of the guideline to help place pharmacological, dietary, and surgical recommendations in a clinical context. The limited number of studies and low certainty of evidence in this population underscores the need for higher-quality data and etiology-specific treatments. More research is needed to evaluate effective therapies for infants with epilepsy, as well as the impact these therapies have on long-term developmental and mortality outcomes.
- 8 April 2026
- Published by SAGE Publications in Epilepsy Currents
- Vol. 26 (3) , 174-202
Open AccessAmerican Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
This practice guideline from the American Epilepsy Society provides evidence-based recommendations for pharmacological, dietary, and surgical therapies for epilepsy for infants and children from 1 month of age to <36 months. The multidisciplinary panel updated an existing systematic review, which was funded by the Patient-Centered Outcomes Research Institute and conducted by ECRI (formerly the Emergency Care Research Institute) on behalf of the Agency for Healthcare Research and Quality. The updated review used the same search strategy, inclusion/exclusion criteria, and Grading of Recommendations Assessment, Development and Education methodology, and added studies from August 2021 through September 2025 that were not in the original systematic review. As with the previous review, West syndrome and infantile spasms were excluded from this guideline, as existing treatment guidance is already available for infantile epileptic spasms. While many of the recommendations are conditional due to low certainty of evidence, the panel made two strong recommendations: (1) hemispherectomy/hemispherotomy surgery is recommended for infants and children <36 months of age with drug resistant epilepsy secondary to select underlying lesional pathologies, including but not limited to hemimegaloencephaly, Rasmussen's encephalitis, Sturge-Weber syndrome, perinatal stroke, and hemispheric cortical dysplasia; and (2) intralobar, multilobar, or focal resections or posterior disconnections for drug-resistant focal or lesional epilepsy in this same age range. A treatment algorithm was developed based on evidence and expert opinion as part of the guideline to help place pharmacological, dietary, and surgical recommendations in a clinical context. The limited number of studies and low certainty of evidence in this population underscores the need for higher-quality data and etiology-specific treatments. More research is needed to evaluate effective therapies for infants with epilepsy, as well as the impact these therapies have on long-term developmental and mortality outcomes.
- 20 September 2023
- Published by Elsevier in Nursing Outlook
- Vol. 71 (6) , 102052
Physical activity interventions for cancer-related fatigue: A scoping review of randomized controlled trials from a Nursing Science Precision Health Model perspective
- 20 September 2023
- Published by Elsevier in Nursing Outlook
- Vol. 71 (6) , 102052
Physical activity interventions for cancer-related fatigue: A scoping review of randomized controlled trials from a Nursing Science Precision Health Model perspective